Safety and bioequivalency of three formulations of respiratory syncytial virus-enriched immunoglobulin.

Respiratory syncytial virus (RSV) causes serious illness (lower respiratory illness) in preterm infants. RSV antibody-enriched immunoglobulin (RSVIG) that was lyophilized (LYO) protected against RSV lower respiratory illness. The Food and Drug Administration now requires an additional viral inactiva...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Groothuis, J R, Simoes, E A, Lehr, M V, Kramer, A A, Hemming, V G, Rodriguez, W J, Arrobio, J, Welliver, R C, Siber, G R
Formato: Artigo
Idioma:Inglês
Publicado em: 1995
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC162602/
https://ncbi.nlm.nih.gov/pubmed/7793870
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados